Growth Metrics

OmniAb (OABI) Non-Current Assets (2021 - 2026)

OmniAb (OABI) reported Non-Current Assets of $228.5 million for Q1 2026, down 9.53% year-over-year from $252.6 million in Q1 2025, and down 2.99% on a QoQ basis from $235.6 million in Q4 2025.

OmniAb (OABI) has 6 years of Non-Current Assets data on file, last reported at $228.5 million in Q1 2026.

  • Quarterly Non-Current Assets fell 9.53% year-over-year to $228.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $955.5 million (down 8.56% YoY) and the FY2025 annual result came in at $235.6 million, down 8.49% from the prior year.
  • Non-Current Assets eased to $228.5 million in Q1 2026 per OABI's latest filing, from $235.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $296.3 million in Q4 2022 and bottomed at $228.5 million in Q1 2026.
  • The 5-year median for Non-Current Assets is $257.4 million (2024), against an average of $260.5 million.
  • The widest annual swing landed in 2023, when Non-Current Assets advanced 23.82%; it then decreased 9.53% in 2026.
  • Tracing OABI's Non-Current Assets over 5 years: stood at $296.3 million in 2022, then fell by 5.38% to $280.3 million in 2023, then retreated by 8.17% to $257.4 million in 2024, then decreased by 8.49% to $235.6 million in 2025, then fell by 2.99% to $228.5 million in 2026.
  • Per Business Quant, the three latest OABI Non-Current Assets figures stand at $228.5 million (Q1 2026), $235.6 million (Q4 2025), and $243.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 228.53 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 228.53 Mn
Dec 31, 2025 235.57 Mn
Sep 30, 2025 243.34 Mn
Jun 30, 2025 248.06 Mn
Mar 31, 2025 252.60 Mn
Dec 31, 2024 257.42 Mn
Sep 30, 2024 264.95 Mn
Jun 30, 2024 269.96 Mn
Mar 31, 2024 275.84 Mn
Dec 31, 2023 280.32 Mn
Sep 30, 2023 284.86 Mn
Jun 30, 2023 289.30 Mn
Mar 31, 2023 291.96 Mn
Dec 31, 2022 296.26 Mn
Sep 30, 2022 237.19 Mn
Jun 30, 2022 236.10 Mn
Mar 31, 2022 235.80 Mn
Dec 31, 2021 281.92 Mn
Sep 30, 2021 235.75 Mn